vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Enpro Inc. (NPO). Click either name above to swap in a different company.
Enpro Inc. is the larger business by last-quarter revenue ($295.4M vs $205.4M, roughly 1.4× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -10.8%, a 19.1% gap on every dollar of revenue. On growth, Enpro Inc. posted the faster year-over-year revenue change (14.3% vs 12.9%). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 7.1%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Enpro is a US-based industrial technology company that designs and manufactures products and materials for technology-intensive sectors. The company serves industries such as semiconductors, aerospace, power generation, heavy-duty trucking, agricultural machinery, chemical processing, pulp and paper, and life sciences from 61 primary manufacturing facilities located in 12 countries, worldwide. It is organized under three segments: Sealing Technologies, Advanced Surface Technologies, and Engin...
COLL vs NPO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $295.4M |
| Net Profit | $17.0M | $-32.0M |
| Gross Margin | 62.5% | 42.1% |
| Operating Margin | 29.6% | 11.2% |
| Net Margin | 8.3% | -10.8% |
| Revenue YoY | 12.9% | 14.3% |
| Net Profit YoY | 35.3% | -330.2% |
| EPS (diluted) | $0.48 | $-1.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $295.4M | ||
| Q3 25 | $209.4M | $286.6M | ||
| Q2 25 | $188.0M | $288.1M | ||
| Q1 25 | $177.8M | $273.2M | ||
| Q4 24 | $181.9M | $258.4M | ||
| Q3 24 | $159.3M | $260.9M | ||
| Q2 24 | $145.3M | $271.9M | ||
| Q1 24 | $144.9M | $257.5M |
| Q4 25 | $17.0M | $-32.0M | ||
| Q3 25 | $31.5M | $21.6M | ||
| Q2 25 | $12.0M | $26.4M | ||
| Q1 25 | $2.4M | $24.5M | ||
| Q4 24 | $12.5M | $13.9M | ||
| Q3 24 | $9.3M | $19.8M | ||
| Q2 24 | $19.6M | $26.7M | ||
| Q1 24 | $27.7M | $12.5M |
| Q4 25 | 62.5% | 42.1% | ||
| Q3 25 | 61.7% | 41.9% | ||
| Q2 25 | 57.7% | 43.3% | ||
| Q1 25 | 54.8% | 43.3% | ||
| Q4 24 | 54.0% | 42.3% | ||
| Q3 24 | 60.8% | 42.3% | ||
| Q2 24 | 62.5% | 43.8% | ||
| Q1 24 | 63.1% | 41.2% |
| Q4 25 | 29.6% | 11.2% | ||
| Q3 25 | 29.7% | 14.3% | ||
| Q2 25 | 18.7% | 15.9% | ||
| Q1 25 | 12.2% | 15.3% | ||
| Q4 24 | 20.9% | 12.5% | ||
| Q3 24 | 21.9% | 13.1% | ||
| Q2 24 | 32.7% | 17.7% | ||
| Q1 24 | 34.1% | 10.9% |
| Q4 25 | 8.3% | -10.8% | ||
| Q3 25 | 15.0% | 7.5% | ||
| Q2 25 | 6.4% | 9.2% | ||
| Q1 25 | 1.4% | 9.0% | ||
| Q4 24 | 6.9% | 5.4% | ||
| Q3 24 | 5.9% | 7.6% | ||
| Q2 24 | 13.5% | 9.8% | ||
| Q1 24 | 19.1% | 4.9% |
| Q4 25 | $0.48 | $-1.50 | ||
| Q3 25 | $0.84 | $1.01 | ||
| Q2 25 | $0.34 | $1.25 | ||
| Q1 25 | $0.07 | $1.15 | ||
| Q4 24 | $0.36 | $0.65 | ||
| Q3 24 | $0.27 | $0.94 | ||
| Q2 24 | $0.52 | $1.27 | ||
| Q1 24 | $0.71 | $0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $114.7M |
| Total DebtLower is stronger | — | $655.3M |
| Stockholders' EquityBook value | $301.7M | $1.5B |
| Total Assets | $1.7B | $2.7B |
| Debt / EquityLower = less leverage | — | 0.42× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $114.7M | ||
| Q3 25 | $285.9M | $132.9M | ||
| Q2 25 | $222.2M | $107.1M | ||
| Q1 25 | $197.8M | $240.3M | ||
| Q4 24 | $162.8M | $236.3M | ||
| Q3 24 | $120.0M | $206.9M | ||
| Q2 24 | $271.6M | $175.9M | ||
| Q1 24 | $318.0M | $163.9M |
| Q4 25 | — | $655.3M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $640.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $644.9M |
| Q4 25 | $301.7M | $1.5B | ||
| Q3 25 | $274.8M | $1.5B | ||
| Q2 25 | $232.2M | $1.5B | ||
| Q1 25 | $234.4M | $1.5B | ||
| Q4 24 | $228.8M | $1.4B | ||
| Q3 24 | $234.3M | $1.5B | ||
| Q2 24 | $216.6M | $1.4B | ||
| Q1 24 | $222.2M | $1.4B |
| Q4 25 | $1.7B | $2.7B | ||
| Q3 25 | $1.6B | $2.4B | ||
| Q2 25 | $1.6B | $2.4B | ||
| Q1 25 | $1.6B | $2.5B | ||
| Q4 24 | $1.7B | $2.5B | ||
| Q3 24 | $1.6B | $2.5B | ||
| Q2 24 | $1.1B | $2.5B | ||
| Q1 24 | $1.1B | $2.5B |
| Q4 25 | — | 0.42× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.45× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.46× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | — |
| Free Cash FlowOCF − Capex | $122.4M | — |
| FCF MarginFCF / Revenue | 59.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | 4.1% |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | — | ||
| Q3 25 | $78.4M | $65.3M | ||
| Q2 25 | $72.4M | $52.2M | ||
| Q1 25 | $55.4M | $21.0M | ||
| Q4 24 | $84.6M | $59.4M | ||
| Q3 24 | $-9.0M | $54.0M | ||
| Q2 24 | $67.4M | $43.2M | ||
| Q1 24 | $61.9M | $6.3M |
| Q4 25 | $122.4M | — | ||
| Q3 25 | $78.3M | $53.4M | ||
| Q2 25 | $72.4M | $42.3M | ||
| Q1 25 | $54.6M | $13.0M | ||
| Q4 24 | $84.1M | $49.1M | ||
| Q3 24 | $-9.2M | $48.3M | ||
| Q2 24 | $67.1M | $38.3M | ||
| Q1 24 | $61.4M | $-1.9M |
| Q4 25 | 59.6% | — | ||
| Q3 25 | 37.4% | 18.6% | ||
| Q2 25 | 38.5% | 14.7% | ||
| Q1 25 | 30.7% | 4.8% | ||
| Q4 24 | 46.2% | 19.0% | ||
| Q3 24 | -5.8% | 18.5% | ||
| Q2 24 | 46.2% | 14.1% | ||
| Q1 24 | 42.3% | -0.7% |
| Q4 25 | 0.3% | 4.1% | ||
| Q3 25 | 0.1% | 4.2% | ||
| Q2 25 | 0.0% | 3.4% | ||
| Q1 25 | 0.4% | 2.9% | ||
| Q4 24 | 0.3% | 4.0% | ||
| Q3 24 | 0.2% | 2.2% | ||
| Q2 24 | 0.2% | 1.8% | ||
| Q1 24 | 0.4% | 3.2% |
| Q4 25 | 7.25× | — | ||
| Q3 25 | 2.49× | 3.02× | ||
| Q2 25 | 6.05× | 1.98× | ||
| Q1 25 | 22.92× | 0.86× | ||
| Q4 24 | 6.75× | 4.27× | ||
| Q3 24 | -0.96× | 2.73× | ||
| Q2 24 | 3.44× | 1.62× | ||
| Q1 24 | 2.23× | 0.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
NPO
| Sealing Technologies Segment | $187.0M | 63% |
| General Industrial | $71.3M | 24% |
| Power Generation | $19.9M | 7% |
| Oiland Gas Market | $15.0M | 5% |
| Semiconductors | $2.2M | 1% |
